Jennifer Jarrett

Ms. Jarrett most recently served as Chief Financial Officer of Medivation, where she was responsible for finance, accounting, information technology, investor relations, strategy and business development.

Prior to Medivation, Jennifer spent 20 years in investment banking, most of that time covering biotechnology companies. Most recently, Ms. Jarrett served as a Managing Director at Citigroup where she headed up their west coast life sciences investment banking group. Prior to Citigroup, Ms. Jarrett worked in the investment banking divisions of Credit Suisse, Donaldson, Lufkin & Jenrette, Merrill Lynch and Kidder Peabody. Jennifer currently serves on the Board of Directors of Audentes Therapeutics. Jennifer received her M.B.A from the Stanford Graduate School of Business and her undergraduate degree in Economics from Dartmouth College.